Treasurer of the State of North Carolina
NTLA icon

Treasurer of the State of North Carolina’s Intellia Therapeutics NTLA Stock Holding History

Treasurer of the State of North Carolina’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,010
Closed -$404K – 1039
2021
Q3 		$404K Buy
+3,010
New +$456K ﹤0.01% 1017

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Treasurer of the State of North Carolina's NTLA Position: Q4 2021 in Review

Treasurer of the State of North Carolina sold out of Intellia Therapeutics (NTLA) in Q4 2021, closing a stake of 3,010 shares — an estimated $404K sold.

Treasurer of the State of North Carolina first reported a position in NTLA in Q3 2021 and held it in 1 quarter. The position peaked at $404K in Q3 2021. 372 funds tracked by Wall St. Rank hold NTLA as of Q4 2021.

  • Treasurer of the State of North Carolina reported no remaining Intellia Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 3,010 Intellia Therapeutics shares in Q4 2021, an estimated $404K.
  • Treasurer of the State of North Carolina first reported a position in Intellia Therapeutics in Q3 2021 and held it in 1 quarter.
  • Treasurer of the State of North Carolina's Intellia Therapeutics position peaked at $404K in Q3 2021.
  • 372 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2021.

Based on Treasurer of the State of North Carolina's 13F filing for Q4 2021, filed 14 Feb 2022.